Filing Details
- Accession Number:
- 0001209191-11-052144
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-19 13:12:34
- Reporting Period:
- 2011-10-15
- Filing Date:
- 2011-10-19
- Accepted Time:
- 2011-10-19 13:12:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107332 | Dendreon Corp | DNDN | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242879 | David Urdal | 1301 2Nd Ave Suite 3200 Seattle WA 98101 | Svp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-10-15 | 5,313 | $9.65 | 582,802 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-10-17 | 2,036 | $9.65 | 580,766 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Billionaire Hedge Funds
